HIGHLIGHTS
- who: Angioletta Lasagna from the Papa Giovanni XXIII Hospital, Italy University of Genoa, Italy have published the Article: Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir, in the Journal: (JOURNAL) of 16/06/2021
SUMMARY
Coronavirus disease (COVID-19) in patients undergoing hematopoietic stem_cell transplantation (HSCT) is a major issue. A systematic review has reported that the mortality rate of COVID-19 was 17% (95% CI=0.12-0.24) in auto-HSCT . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.